glp 1 covered by blue cross bcbs glp-1 coverage 2025 Excellus clarifies ahead of 2026 formulary changes Does Blue Shield – IBX members face GLP-1 drug

On post hoc analyses, we further evaluated the comparative effectiveness of semaglutide versus dulaglutide in the expanded population to contextualize whether a reduction in the primary endpoint, relative to the comparisons including tirzepatide, was similar or greater

This conversation reframes exercise not as punishment or weight loss driven, but as a powerful tool for resilience, independence, and quality of life

More serious but less common adverse effects include pancreatitis, gallbladder disease, and hypoglycemia (particularly when combined with insulin or sulfonylureas)

Transplantation 103 , 14051413 (2019)